AGA GUIDELINES Bundle (free trial)

Adult Obesity

AGA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512444

Contents of this Issue

Navigation

Page 5 of 9

Treatment Figure 1. Pharmacological Interventions for Adults With Obesity Clinical Decision Support Tool If failure to achieve adequate weight loss (e.g., 5% reduction in total body weight) and/or unable to control weight-related complications, consider change in therapy based on patient factors (switching drugs, endoscopic bariatric procedures, and/or bariatric surgery) a a Selection of the medication or intervention should be based on the clinical profile and needs of the patient including but not limited to complications, patients' preferences, costs, and access to the therapy. Semaglutide Liraglutide Phentermine- topiramate ER Naltrexone- bupropion ER AGA Recommendation Suggest using Mean difference % total body weight loss achieved (placebo subtracted) 10.8% 4.8% 8.5% 3.0%

Articles in this issue

Archives of this issue

view archives of AGA GUIDELINES Bundle (free trial) - Adult Obesity